Some speculation on the future

So where do we the lowly shareholders stand?

What has changed?

The most significant change IMO is that India have finally done something to get control of the grey/black market by way of currency reform and tax and fee reform. These measures should remove many of the channels used by black market operators to fell and sell Sandalwood and its oils.

Allied to this is the creation of a base price via QIN's sale to Young Living which gives the Indian authorities and Chinese authorities a benchmark for establishing duties etc on the product.

The Young Living sale also IMO gives a strong reason to refrain from exercising a put - since the price is above what QIN has used as their valuation in the previous years annual report.

Will Galderma decide to reenter the market at this price - interesting to observe - and I gather there is still around 50% of the harvest available.

Where does Qin stand with the FDA trials ? Again this will be interesting to be informed in due course.

All IMO and DYOR of course